Bajaj Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-12.8%1-day move

₹338.45

prior close

₹300.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+3.0+4.5+5.3+4.2-12.8-12.5-12.8-16.4-18.7-10.5-11.9-16.7+1.7—

Up moveDown movePending

AI summary

Bajaj Healthcare Limited filed its quarterly statement confirming NO deviation or variation in the utilisation of Rs. 52.71 Crores raised through conversion of convertible warrants into equity shares. The funds were received on March 18, 2026 upon exercise of conversion options by the Promoter. The original preferential issue was undersubscribed - the company aimed to raise Rs. 207 Crores but received Rs. 152.26 Crores initially, with the balance Rs. 52.71 Crores received during Q4 FY26. The funds are being deployed as planned: Rs. 150 Crores for loan repayment, Rs. 3.16 Crores utilized for capital expenditure (out of Rs. 35 Crores allocated), and Rs. 19.84 Crores for general corporate purposes. CARE Ratings Limited is the monitoring agency. Both the Audit Committee and auditors have no comments.

Likely market impact

The filing is positive for shareholders as it confirms proper utilization of funds with zero deviation, indicating good corporate governance and adherence to stated objectives.